Federal Register / Vol. 80, No. 77 / Wednesday, April 22, 2015 / Notices 22551 

DEPARTMENT OF JUSTICE 

Antitrust Division 

Notice Pursuant to the National 

Cooperative Research and Production 

Act of 1993—Cooperative Research 

Group on High Efficiency Dilute 

Gasoline Engine III 

Notice is hereby given that, on March 

19, 2015, pursuant to section 6(a) of the 

National Cooperative Research and 

Production Act of 1993, 15 U.S.C. 4301 

et seq. (‘‘the Act’’), Southwest Research 

Institute—Cooperative Research Group 

on High-Efficiency Dilute Gasoline 

Engine III (‘‘HEDGE III’’) has filed 

written notifications simultaneously 

with the Attorney General and the 

Federal Trade Commission disclosing 

(1) the identities of the parties to the 

venture and (2) the nature and 

objectives of the venture. The 

notifications were filed for the purpose 

of invoking the Act’s provisions limiting 

the recovery of antitrust plaintiffs to 

actual damages under specified 

circumstances. 

Pursuant to section 6(b) of the Act, the 

identities of the parties to the venture 

are: Borgwarner, Inc., Auburn Hills, MI; 

Caterpillar, Inc., Peoria, IL; Chrysler 

Group, LLC, Auburn Hills, MI; 

Continental Automotive GMBH, 

Regensburg, GERMANY; Cummins, Inc., 

Columbus, IN; Delphi Corporation, 

Auburn Hills, MI; Denso International 

America, Inc., Southfield, MI; Diamond 

Electric, Dundee, MI; Eaton Corporation, 

Southfield, MI; Federal Mogul, 

Plymouth, MI; Ford Motor Company, 

Dearborn, MI; GM Global Technology 

Operations, LLC, Detroit, MI; Hitachi 

America, Ltd., Farmington Hills, MI; 

Honda R&D, Tochigi, JAPAN; 

Honeywell International, Inc., Torrance, 

CA; Hyundai Motor Company, Seoul, 

KOREA; IHI Corporation, Yokohama, 

JAPAN; Jaguar Land Rover, Coventry, 

UNITED KINGDOM; Lubrizol 

Corporation, Wickliffe, OH; NGK Spark 

Plug Company, Nagoya, JAPAN; Peugeot 

Citroen Automobiles, VelizyVillacoublay, Cedex, FRANCE; Renault, 

Boulogne Billancourt, FRANCE; Sejong 

Industrial Co., Ltd., Kyounggi-do, 

KOREA; Tenneco Automotive Operating 

Co., Inc., Grass Lake, MI; Toyota Motor 

Corporation, Shizuoka, JAPAN; 

Volkswagen Group of America, Inc., 

Herndon, VA; and Woodward, Inc., Fort 

Collins, CO. 

The general area of HEDGE III’s 

planned activity is to develop the most 

cost-effective solutions for future 

gasoline engine applications. The 

emissions goals include the most 

stringent regulations in each of the three 

developed markets, Asia, Europe, and 

North America. HEDGE III will target 

the LEV III standards and extensively 

investigate cold-start technologies and 

monitor PM/PN emissions on a regular 

basis. The efficiency goals include both 

practical thermal efficiency targets, in 

terms of BSFC goals on specific 

platforms, as well as overall thermal 

efficiency goals to achieve a ‘‘best in 

class’’ efficiency level. 

Patricia A. Brink, 

Director of Civil Enforcement, Antitrust 

Division. 

[FR Doc. 2015–09321 Filed 4–21–15; 8:45 am] 

BILLING CODE 4410–11–P 

DEPARTMENT OF JUSTICE 

Antitrust Division 

Notice Pursuant to the National 

Cooperative Research And Production 

Act of 1993—Cooperative Research 

Group on Advanced Engine Fluids 

Notice is hereby given that, on March 

20, 2015, pursuant to Section 6(a) of the 

National Cooperative Research and 

Production Act of 1993, 15 U.S.C. 4301 

et seq. (‘‘the Act’’), Southwest Research 

Institute—Cooperative Research Group 

on Advanced Engine Fluids (‘‘AEF’’) has 

filed written notifications 

simultaneously with the Attorney 

General and the Federal Trade 

Commission disclosing (1) the identities 

of the parties to the venture and (2) the 

nature and objectives of the venture. 

The notifications were filed for the 

purpose of invoking the Act’s provisions 

limiting the recovery of antitrust 

plaintiffs to actual damages under 

specified circumstances. 

Pursuant to Section 6(b) of the Act, 

the identities of the parties to the 

venture are: Caterpillar Inc., Lafayette, 

IN; Cummins Inc., Columbus, IN; 

ExxonMobil Research and Engineering 

Co., Paulsboro, NJ; Infineum USA L.P., 

Linden, NJ; Sasol Technology (PTY) 

Ltd., Rosebank, SOUTH AFRICA; Total 

Marketing Services, Puteaux, FRANCE; 

and Toyota Motor Corp., Shizuoka, 

JAPAN. The general area of AEF’s 

planned activity is to develop a 

fundamental understanding of the 

interaction between fuel and lubricant 

properties and engine operation, 

particularly for advanced engine 

technologies that are moving toward 

production. The focus of the program 

will be to develop and apply advanced 

analytical methods to investigate the 

detailed chemical and physical 

interactions between the combustion 

system and the fuels and lubricants. 

Initial projects focus on four distinct 

areas: (1) Investigation of the 

fundamental processes causing LSPI 

and potential mitigation strategies 

through controls and hardware 

optimization; (2) investigation of fuel 

octane, physical properties, and 

chemistry on knock resistance and 

engine efficiency; (3) evaluation of the 

impact of dual-fuel combustion 

strategies on lubricating oil performance 

and chemistry; and (4) evaluation of 

alternative fuel chemistry and 

properties on engine efficiency and 

performance. 

Patricia A. Brink, 

Director of Civil Enforcement, Antitrust 

Division. 

[FR Doc. 2015–09319 Filed 4–21–15; 8:45 am] 

BILLING CODEP 

DEPARTMENT OF JUSTICE 

Antitrust Division 

Notice Pursuant to the National 

Cooperative Research and Production 

Act of 1993—Opendaylight Project, Inc. 

Notice is hereby given that, on March 

25, 2015 pursuant to Section 6(a) of the 

National Cooperative Research and 

Production Act of 1993, 15 U.S.C. 4301 

et seq. (‘‘the Act’’), OpenDaylight 

Project, Inc. (‘‘OpenDaylight’’) has filed 

written notifications simultaneously 

with the Attorney General and the 

Federal Trade Commission disclosing 

changes in its membership. The 

notifications were filed for the purpose 

of extending the Act’s provisions 

limiting the recovery of antitrust 

plaintiffs to actual damages under 

specified circumstances. Specifically, 

IIX Inc., Palo Alto, CA; Spirent 

Communications Inc., Sunnyvale, CA; 

and CA Inc., Portsmouth, NH, have been 

added as parties to this venture. 

No other changes have been made in 

either the membership or planned 

activity of the group research project. 

Membership in this group research 

project remains open, and OpenDaylight 

intends to file additional written 

notifications disclosing all changes in 

membership. 

On May 23, 2013, OpenDaylight filed 

its original notification pursuant to 

Section 6(a) of the Act. The Department 

of Justice published a notice in the 

Federal Register pursuant to Section 

6(b) of the Act on July 1, 2013 (78 FR 

39326). 

The last notification was filed with 

the Department on December 24, 2014. 

A notice was published in the Federal 


asabaliauskas on DSK5VPTVN1PROD with NOTICES
22552 Federal Register / Vol. 80, No. 77 / Wednesday, April 22, 2015 / Notices 

Register pursuant to Section 6(b) of the 

Act on February 6, 2015 (80 FR 6768). 

Patricia A. Brink, 

Director of Civil Enforcement, Antitrust 

Division. 

[FR Doc. 2015–09317 Filed 4–21–15; 8:45 am] 

BILLING CODE P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. DEA–392] 

Importer of Controlled Substances 

Application: Unither Manufacturing, 

LLC 

ACTION: Notice of application. 

DATES: Registered bulk manufacturers of 

the affected basic class, and applicants 

therefore, may file written comments on 

or objections to the issuance of the 

proposed registration in accordance 

with 21 CFR 1301.34(a) on or before 

May 22, 2015. Such persons may also 

file a written request for a hearing on 

the application pursuant to 21 CFR 

1301.43 on or before May 22, 2015. 

ADDRESSES: Written comments should 

be sent to: Drug Enforcement 

Administration, Attention: DEA Federal 

Register Representative/ODXL, 8701 

Morrissette Drive, Springfield, Virginia 

22152. Request for hearings should be 

sent to: Drug Enforcement 

Administration, Attention: Hearing 

Clerk/LJ, 8701 Morrissette Drive, 

Springfield, Virginia 22152. 

SUPPLEMENTARY INFORMATION: The 

Attorney General has delegated his 

authority under the Controlled 

Substances Act to the Administrator of 

the Drug Enforcement Administration 

(DEA), 28 CFR 0.100(b). Authority to 

exercise all necessary functions with 

respect to the promulgation and 

implementation of 21 CFR part 1301, 

incident to the registration of 

manufacturers, distributors, dispensers, 

importers, and exporters of controlled 

substances (other than final orders in 

connection with suspension, denial, or 

revocation of registration) has been 

redelegated to the Deputy Assistant 

Administrator of the DEA Office of 

Diversion Control (‘‘Deputy Assistant 

Administrator’’) pursuant to section 7 of 

28 CFR part 0, appendix to subpart R. 

In accordance with 21 CFR 

1301.34(a), this is notice that on July 10, 

2014, Unither Manufacturing LLC, 331 

Clay Road, Rochester, New York 14623 

applied to be registered as an importer 

of methylphenidate (1724), a basic class 

of controlled substance listed in 

schedule II. 

The company plans to import the 

listed substance as a raw material for 

updated testing purposes for EU 

customer requirements. 

The company plans to import the 

listed controlled substance in finished 

dosage form (FDF) from foreign sources 

for analytical testing and clinical trials 

in which the foreign FDF will be 

compared to the company’s own 

domestically-manufactured FDF. This 

analysis is required to allow the 

company to export domesticallymanufactured FDF to foreign markets. 

Dated: April 14, 2015. 

Joseph T. Rannazzisi, 

Deputy Assistant Administrator. 

[FR Doc. 2015–09337 Filed 4–21–15; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. DEA–392] 

Importer of Controlled Substances 

Application: Sigma-Aldrich 

International GMBH, Sigma Aldrich 

Co., LLC 

ACTION: Notice of application. 

DATES: Registered bulk manufacturers of 

the affected basic classes, and 

applicants therefore, may file written 

comments on or objections to the 

issuance of the proposed registration in 

accordance with 21 CFR 1301.34(a) on 

or before May 22, 2015. Such persons 

may also file a written request for a 

hearing on the application pursuant to 

21 CFR 1301.43 on or before May 22, 

2015. 

ADDRESSES: Written comments should 

be sent to: Drug Enforcement 

Administration, Attention: DEA Federal 

Register Representative/ODXL, 8701 

Morrissette Drive, Springfield, Virginia 

22152. Comments and requests for 

hearings on applications to import 

narcotic raw material are not 

appropriate. 72 FR 3417 (January 25, 

2007). 

SUPPLEMENTARY INFORMATION: The 

Attorney General has delegated his 

authority under the Controlled 

Substances Act to the Administrator of 

the Drug Enforcement Administration 

(DEA), 28 CFR 0.100(b). Authority to 

exercise all necessary functions with 

respect to the promulgation and 

implementation of 21 CFR part 1301, 

incident to the registration of 

manufacturers, distributors, dispensers, 

importer, and exporters of controlled 

substances (other than final orders in 

connection with suspension, denial, or 

revocation of registration) has been 

redelegated to the Deputy Assistant 

Administrator of the DEA Office of 

Diversion Control (‘‘Deputy Assistant 

Administrator’’) pursuant to section 7 of 

28 CFR part 0, appendix to subpart R. 

In accordance with 21 CFR 

1301.34(a), this is notice that on 

February 5, 2015, Sigma-Aldrich 

International GMBH, Sigma Aldrich Co. 

LLC, 3500 Dekalb Street, St. Louis, 

Missouri 63118 applied to be registered 

as an importer of the following basic 

classes of controlled substances: 

Controlled substance Schedule 

Cathinone (1235) .......................... I 

Methcathinone (1237) .................. I 

Mephedrone (4-Methyl-Nmethylcathinone) (1248).I 

N-Ethylamphetamine (1475) ........ I 

Aminorex (1585) ........................... I 

Gamma Hydroxybutyric Acid 

(2010).

I 

Methaqualone (2565) ................... I 

Alpha-ethyltryptamine (7249) ....... I 

Ibogaine (7260) ............................ I 

Lysergic acid diethylamide (7315) I 

Marihuana (7360) ......................... I 

Tetrahydrocannabinols (7370) ..... I 

Mescaline (7381) .......................... I 

4-Bromo-2,5- 

dimethoxyamphetamine (7391).

I 

4-Bromo-2,5- 

dimethoxyphenethylamine 

(7392).

I 

4-Methyl-2,5- 

dimethoxyamphetamine (7395).

I 

2,5-Dimethoxyamphetamine 

(7396).

I 

3,4-Methylenedioxyamphetamine 

(7400).

I 

N-Hydroxy-3,4- 

methylenedioxyamphetamine 

(7402).

I 

3,4-Methylenedioxy-Nethylamphetamine (7404).I 

3,4- 

Methylenedioxymethamphetamine (7405).

I 

4-Methoxyamphetamine (7411) ... I 

Bufotenine (7433) ......................... I 

Diethyltryptamine (7434) .............. I 

Dimethyltryptamine (7435) ........... I 

Psilocybin (7437) .......................... I 

Psilocyn (7438) ............................. I 

1-[1-(2- 

Thienyl)cyclohexyl]piperidine 

(7470).

I 

N-Benzylpiperazine (7493) ........... I 

MDPV (3,4- 

Methylenedioxypyrovalerone) 

(7535).

I 

Heroin (9200) ............................... I 

Normorphine (9313) ..................... I 

Etonitazene (9624) ....................... I 

Amphetamine (1100) .................... II 

Methamphetamine (1105) ............ II 

Methylphenidate (1724) ................ II 

Amobarbital (2125) ....................... II 

Pentobarbital (2270) ..................... II 

Secobarbital (2315) ...................... II 

Glutethimide (2550) ...................... II 


asabaliauskas on DSK5VPTVN1PROD with NOTICES